fbpx

Healthy Returns: A Safer Future

Healthy Returns: A Safer Future | March 10, 2021 | 12:00pm ET

On the one year anniversary of the WHO declaring a pandemic, CNBC takes a look at how far we’ve come, and what needs to be done to make for a safer future for all.

Meg Tirrell speaks to Dr. Luciana Borio, In-Q-Tel VP and Former FDA Acting Chief Scientist, and Dr. Scott Gottlieb, Former FDA Commissioner about the year that was and building a safer future. They explore where we are as an immunized nation with the roll out of the third FDA-authorized vaccine, how the threat of Covid is evolving and the road to reopening.

Hosted by CNBC’s Senior Health & Science Reporter, Meg Tirrell, and featuring interviews with healthcare CEOs, investors & technologists addressing the lasting effects of COVID-19, Healthy Returns livestreams are broadcast on CNBC.com and CNBC social handles.

HOW TO WATCH:


COMING UP: REGISTER FOR OUR 2021 ANNUAL SUMMIT – May 11, 2021

PAST EVENTS: 2020 Livestream | SUMMITS: 2020 | 2019 | 2018

Watch our 2020 Event Highlights

Visit cnbc.com/healthy-returns to find in-depth coverage from the CNBC team about health care innovation.

Speakers

LUCIANA BORIO

Luciana Borio is VP of In-Q-Tel and Former Acting Chief Scientist of FDA.

Scott Gottlieb

Scott Gottlieb, MD is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety.

Dr. Gottlieb is an aggressive advocate for advancing the health of patients, promoting healthcare access, and driving innovation. The agency’s historic and prolific advances in new policy distinguished his tenure as the FDA’s commissioner, in addition to a record-setting number of approvals of novel drugs, medical devices, and generic medicines.

Under his leadership, the FDA advanced new frameworks for the modern and safe and effective oversight of gene therapies, cell based regenerative medicines, targeted drugs, and digital health devices. The agency implemented new reforms to standardize drug reviews and make historic improvements of post market data collection and the use of real world evidence. He promoted policies to reduce death and disease from tobacco, improve food innovation and safety, and aggressively confront addiction crises.

Previously, Dr. Gottlieb served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and before that, as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services, where he helped advance policies to improve healthcare quality and promote the effective use of new medical technologies. A healthcare futurist, he works as a venture capitalist and has been a founder and board member to companies that have developed new medicines and advance the delivery of healthcare.

Dr. Gottlieb is widely published in leading medical journals and periodicals, including The Wall Street Journal, The New York Times, and The Washington Post. He has held editorial positions on the British Medical Journal and the Journal of the American Medical Association. Fortune Magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and again in 2019. Modern Healthcare named Dr. Gottlieb as one of the “Most Influential Physician Executive and Leaders” in its annual survey of 50 physician executives, and Time magazine named Gottlieb one of its “50 People Transforming Healthcare in 2018.”

Dr. Gottlieb was a practicing hospitalist and a Clinical Assistant Professor at the New York University School of Medicine. He is an elected member of the National Academy of Medicine and a Resident Fellow at the American Enterprise Institute in Washington, DC.

Meg Tirrell

Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals. She appears on CNBC's Business Day programming, contributes to CNBC.com and is based at the network's global headquarters in Englewood Cliffs, N.J.

Tirrell has covered development of new drugs for Alzheimer's, cancer and rare diseases, and tracked public health emergencies from Ebola to Zika. Her work has explored why fewer drugs are developed for children, chronicled the sequencing of her own genome, and followed the manufacturing of a flu shot from egg to pharmacy. In 2014, she revealed the agonizing decision-making behind Compassionate Use of unapproved drugs, and in 2016, she reported extensively on drug pricing controversies and the impact of politics on development of new medicines.

Prior to joining CNBC, Tirrell covered the biotechnology industry for Bloomberg News, where she also contributed to Bloomberg Television and Bloomberg Businessweek.

She holds a master's degree in journalism from Northwestern University and a bachelor's degree in English and music from Wellesley College.

PROGRAM DETAILS

Healthy Returns: A Safer Future
March 10, 2021 | 12:00pm ET

On the one year anniversary of the WHO declaring a pandemic, CNBC takes a look at how far we’ve come, and what needs to be done to make for a safer future for all. Meg Tirrell speaks to Dr. Luciana Borio, In-Q-Tel VP and Former FDA Acting Chief Scientist, and Dr. Scott Gottlieb, Former FDA Commissioner about the year that was and building a safer future. They explore where we are as an immunized nation with the roll out of the third FDA-authorized vaccine, how the threat of Covid is evolving and the road to reopening.

Watch all of our Healthy Returns livestreams here

LEARN MORE & SUBSCRIBE

REGISTER FOR THE MAY 11, 2021 SUMMIT.

Subscribe to our Healthy Returns newsletter for exclusive insights on the biggest health care news from our reporters, delivered straight to your inbox every Friday.

Visit cnbc.com/healthy-returns for relevant content from the event and all-things health care investing and innovation.

For additional questions, email events@cnbc.com.

Sponsors

PAST EVENT SPEAKERS